NO20031779D0 - Fremgangsmåte og preparat for behandling av okular hypertensjon og glaukom - Google Patents

Fremgangsmåte og preparat for behandling av okular hypertensjon og glaukom

Info

Publication number
NO20031779D0
NO20031779D0 NO20031779A NO20031779A NO20031779D0 NO 20031779 D0 NO20031779 D0 NO 20031779D0 NO 20031779 A NO20031779 A NO 20031779A NO 20031779 A NO20031779 A NO 20031779A NO 20031779 D0 NO20031779 D0 NO 20031779D0
Authority
NO
Norway
Prior art keywords
glaucoma
preparation
treatment
ocular hypertension
ocular
Prior art date
Application number
NO20031779A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031779L (no
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of NO20031779L publication Critical patent/NO20031779L/no
Publication of NO20031779D0 publication Critical patent/NO20031779D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20031779A 2001-08-23 2003-04-22 Fremgangsmåte og preparat for behandling av okular hypertensjon og glaukom NO20031779D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31411001P 2001-08-23 2001-08-23
PCT/JP2002/008446 WO2003018025A1 (en) 2001-08-23 2002-08-22 Method and composition for treatment of ocular hypertension and glaucoma

Publications (2)

Publication Number Publication Date
NO20031779L NO20031779L (no) 2003-04-22
NO20031779D0 true NO20031779D0 (no) 2003-04-22

Family

ID=23218598

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031779A NO20031779D0 (no) 2001-08-23 2003-04-22 Fremgangsmåte og preparat for behandling av okular hypertensjon og glaukom

Country Status (12)

Country Link
US (1) US20030060511A1 (enExample)
EP (1) EP1420793A1 (enExample)
JP (1) JP2004521960A (enExample)
KR (1) KR20040029012A (enExample)
CN (1) CN1575178A (enExample)
AR (1) AR036276A1 (enExample)
BR (1) BR0205932A (enExample)
CA (1) CA2458230A1 (enExample)
MX (1) MXPA04001604A (enExample)
NO (1) NO20031779D0 (enExample)
WO (1) WO2003018025A1 (enExample)
ZA (1) ZA200302911B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082257A2 (en) * 2002-03-28 2003-10-09 Sucampo Ag Method for treating ocular hypertension and glaucoma
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
WO2012137987A1 (en) * 2011-04-07 2012-10-11 Sucampo Ag Method for treating asthenopia

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932389A (en) * 1974-12-11 1976-01-13 Pfizer Inc. 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP0569046B1 (en) * 1988-09-06 2002-11-13 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) * 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE162074T1 (de) * 1988-10-01 1998-01-15 R Tech Ueno Ltd Oculare hypotensive mittel
US5194429A (en) * 1988-10-01 1993-03-16 K.K. Ueno Seiyaku Oyo Kenkyujo Ocular hypotensive agents
TW249226B (enExample) * 1990-04-04 1995-06-11 Aderk Ueno Kk
US5208256A (en) * 1990-05-22 1993-05-04 R-Tech Ueno, Ltd. Treatment of ocular hypertension with a synergistic combination for ocular administration
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US6458836B1 (en) * 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension

Also Published As

Publication number Publication date
CA2458230A1 (en) 2003-03-06
WO2003018025A1 (en) 2003-03-06
NO20031779L (no) 2003-04-22
MXPA04001604A (es) 2004-07-08
CN1575178A (zh) 2005-02-02
AR036276A1 (es) 2004-08-25
EP1420793A1 (en) 2004-05-26
JP2004521960A (ja) 2004-07-22
US20030060511A1 (en) 2003-03-27
KR20040029012A (ko) 2004-04-03
BR0205932A (pt) 2004-02-17
ZA200302911B (en) 2003-10-14

Similar Documents

Publication Publication Date Title
IS7215A (is) Aðferðir til að meðhöndla nýæðarsjúkdóma í augum
GB2402674B (en) Compositions and methods for the treatment of glaucoma or ocular hypertension
NO20041216L (no) Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
AU2002250250A1 (en) Intravascular device for treatment of hypertension
NO20035609L (no) Fremgangsmate for kontinuerlig naftabehandling
PL366636A1 (en) Pyranoindazoles and their use for the treatment of glaucoma
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
NO20052751D0 (no) Oftalmisk preparat for behandling av okulaer hypertensjon.
NO20034864D0 (no) Preparat for behandling av legemiddelindusert forstoppelse med 15-keto-prostaglandiner
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
DK1267847T3 (da) 5HT2-antagonist til regulering af IOP og behandling af glaucom
NO20040059L (no) Benzo[G]kinolinderivater for behandling av glaukom og myopi
NO20035043D0 (no) Fremgangsmåte for behandling av okular hypertensjon og glaukom
NO20031779L (no) Fremgangsmåte og preparat for behandling av okular hypertensjon og glaukom
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
NO20020369D0 (no) Preparat for forebyggelse og behandling av nyredysfunksjon og -sykdommer
NO20024381D0 (no) Behandling av okular hypertensjon og gluakom
NO20025760L (no) S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser
NO20034738L (no) Fremgangsmåter og mellomprodukter for fremstilling av benzylperoksider
AU2002322769A1 (en) Method for treatment of ocular hypertension and glaucoma
AU2003215820A8 (en) Method for treating ocular hypertension and glaucoma
AU2001270642A1 (en) Method for the treatment of glaucoma and ocular hypertension by administering nucleotides
NO20035706D0 (no) Antihistaminer for behandling av nesetetthet og neseobstruksjon
AU2003216547A8 (en) Compositions and methods for treating glaucoma and ocular hypertension

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application